Mintaka Foundation
Geneva-registered charitable foundation (est. 2005) that conducts translational research to develop low-cost, purpose-designed medicines and vaccine technologies for use in low-resource settings. Activities include protein engineering, formulation development, preclinical studies, early-phase clinical safety testing, partnership building, local manufacturing transfer, and out-licensing for commercial sustainability.
Industries
Nr. of Employees
small (1-50)
Products
Engineered antiviral protein topical microbicide (gel)
A pharmaceutically formulated topical gel containing an engineered human-protein-based antiviral intended for pre-exposure application to reduce HIV transmission risk.
Heat-stable dry oxytocin formulation for inhalation with low-cost disposable inhaler
A dry, stabilized oxytocin formulation developed for non-injectable inhalation delivery using a robust inexpensive disposable inhaler to enable treatment of postpartum hemorrhage outside settings with trained injectors.
Synthetic designer vaccine platform with nanoparticle carriers
A platform for inexpensive synthesis of fully synthetic vaccine constructs and the use of functionalized nanoparticles as carriers to exploit insights into immune recognition for difficult infectious diseases.
Engineered antiviral protein topical microbicide (gel)
A pharmaceutically formulated topical gel containing an engineered human-protein-based antiviral intended for pre-exposure application to reduce HIV transmission risk.
Heat-stable dry oxytocin formulation for inhalation with low-cost disposable inhaler
A dry, stabilized oxytocin formulation developed for non-injectable inhalation delivery using a robust inexpensive disposable inhaler to enable treatment of postpartum hemorrhage outside settings with trained injectors.
Synthetic designer vaccine platform with nanoparticle carriers
A platform for inexpensive synthesis of fully synthetic vaccine constructs and the use of functionalized nanoparticles as carriers to exploit insights into immune recognition for difficult infectious diseases.
Expertise Areas
- Protein engineering and biologics development
- Formulation development for topical and inhalation products
- Vaccine design and nanoparticle-based delivery
- Preclinical immunization studies and translational research
Key Technologies
- Engineered antiviral protein therapeutics
- Topical microbicide gel formulation
- Dry-stabilized inhalation formulations
- Disposable inhaler-mediated delivery